Development of an efficient liposomal DOX delivery formulation for HCC therapy by targeting CK2α.
Zhao R, Cheng S, Bai X, Zhang D, Fang H, Che W, Zhang W, Zhou Y, Duan W, Liang Q, Xiao L, Nie G, Hou Y.
Zhao R, et al. Among authors: zhang w, zhang d.
Biotechnol J. 2024 Apr;19(4):e2400050. doi: 10.1002/biot.202400050.
Biotechnol J. 2024.
PMID: 38651271